Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer in comparison with chemoradiotherapy alone

BACKGROUND: Durvalumab after concurrent chemoradiotherapy (CCRT) for locally advanced non‐small cell lung cancer (LA‐NSCLC) has been found to significantly improve overall survival (OS). However, the effect of durvalumab on local control remains unclear. Here, we evaluated the effect of the durvalum...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Takanori, Saito, Satoshi, Iino, Misaki, Aoshika, Tomomi, Ryuno, Yasuhiro, Ohta, Tomohiro, Igari, Mitsunobu, Hirai, Ryuta, Kumazaki, Yu, Miura, Yu, Kaira, Kyoichi, Kagamu, Hiroshi, Noda, Shin‐ei, Kato, Shingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812072/
https://www.ncbi.nlm.nih.gov/pubmed/33289347
http://dx.doi.org/10.1111/1759-7714.13764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812072/
https://www.ncbi.nlm.nih.gov/pubmed/33289347
http://dx.doi.org/10.1111/1759-7714.13764

Ejemplares similares